European Medicines Agency approval could stipulate age range, says Emer Cooke
The Oxford/AstraZeneca vaccine may be authorised only for younger people in Europe, because there is insufficient data on how well it works in the over-65s, the head of the regulatory body has suggested.
The European Medicines Agency (EMA) is expected to authorise the AstraZeneca vaccine at the end of this week, a month after it was approved in the UK.
Continue reading...from The Guardian https://ift.tt/39lQTEN
